09:20 AM EDT, 04/11/2025 (MT Newswires) -- Health care stocks were mixed premarket Friday with the Health Care Select Sector SPDR Fund ( XLV ) was marginally lower and the iShares Biotechnology ETF (IBB) was up 0.4% higher recently.

Novartis ( NVS ) plans to invest $23 billion in building and expanding 10 facilities in the US over the next five years in response to possible drug import tariffs under the Trump administration, Reuters reported, citing the company. Shares of Novartis ( NVS ) advanced by over 2% premarket.

Verve Therapeutics ( VERV ) shares were up more than 8% after the company said the US Food and Drug Administration granted fast track designation for its experimental VERVE-102 treatment for hyperlipidemia and high lifetime cardiovascular risk to lower low-density lipoprotein cholesterol.

Perspective Therapeutics ( CATX ) shares rose past 6% after the company said it has dosed the first patient in a new cohort of its phase 1/2a trial evaluating [212Pb]VMT01 as a monotherapy for melanoma patients with confirmed positive MC1R imaging scans.